For Q320, according to BioMedGPS’ SmartTRAK Financial Dashboard, WW Advanced Wound Care (AWC) revenues for Advanced Dressings, External Devices and Biologics increased slightly YoY.
3M* remained the WW market leader, up +1.5% YoY, driven by tentative signs of improvement in elective procedures. WW Advanced Dressings returned to positive growth, with mixed performance among leading players. US Skin/Dermal Substitute (CTP) revenue rebounded over Q319, driven by a whopping performance by Organogenesis, while WW NPWT was down slightly YoY, with single-use down and traditional devices flat.
- Complete Market Overview and Highlights
- Companies' Revenues and Market Shares
- The Trend in Smaller Deals
- Sequential Improvements Seen Among AWC Market Leaders
- Wound Biologics – Wide Differences in Performance Among Market Leaders
- NPWT – Gaining Traction
- Advanced Dressings – A Slight Uptick
- Q320 Growth in Constant and Reported Key Companies
BioMedGPS’ SmartTRAK Financial Dashboard estimates Q320 revenues for WW Advanced Dressings, Biologics and External Devices (primarily NPWT) come in relatively flat at $*, up%* YoY. Global shares for Q320 came in relatively stable YoY with the US up slightly and EU and ROW down slightly. The US saw increases of ...
*The entire article, including revenue, shares and links can only be viewed by SmartTRAK subscribers to this module. For more information on how to receive a demo and subscribe, please click the button below.
SmartTRAK is a comprehensive, easy-to-use, business intelligence solution that networks an entire organization with real-time market data and analysis. Used by the 15 top Advanced Wound Care companies and 8 of the 10 top Orthopedic companies, SmartTRAK transforms the delivery of healthcare business information into a cost-effective solution for life science corporations to increase proficiency, improve productivity and reduce cost.